Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free
$707M 0.1%Beat EPS +4.2%
Total revenue, Q2 '26 (USD).

Did Medpace Beat Earnings?

Medpace (MEDP) reported Q2 '26 revenue of $707M, up 17.2% year-over-year, with reported EPS of $4.25. That topped the $4.08 analyst estimate by 4.2% — an earnings beat.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Medpace’s job postings, web traffic, and employee business outlook. See the full MEDP stock analysis or the earnings calendar for upcoming reports.

MEDP Earnings Surprise History (EPS vs. Estimate)

QuarterEstimated EPSReported EPSSurprise
Q2 '26 $4.08 $4.25 Beat +4.2%
Q1 '26 $3.96 $4.28 Beat +8.1%
Q4 '25 $4.18 $4.67 Beat +11.7%
Q3 '25 $3.57 $3.86 Beat +8.1%
Q2 '25 $3.00 $3.10 Beat +3.3%
Q1 '25 $3.07 $3.67 Beat +19.5%

Medpace Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue533M537M559M603M660M708M707M707M
Gross margin31.7%33.2%31.9%29.8%29.8%29.0%27.8%28.5%
Operating margin21.1%23.4%20.3%20.9%21.5%21.6%20.0%20.8%
Net income96M117M115M90M111M135M124M121M
Net margin18.1%21.8%20.5%15.0%16.8%19.1%17.5%17.2%
EPS$3.01$3.68$3.67$3.10$3.86$4.67$4.28$4.25

Medpace Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, Medpace’s quarterly revenue moved from $533M to $707M. Net margin compressed from 18.1% to 17.2%, against a 28.5% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Medpace has beaten Wall Street EPS estimates in 8 of its last 8 reported quarters.

When Is Medpace’s Next Earnings Date?

Medpace reports earnings on a quarterly schedule. Its most recent report covered Q2 '26. For the confirmed upcoming date — and every other company reporting soon — see the MEDP earnings calendar.

Frequently Asked Questions: Medpace Earnings

Medpace's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

Medpace reported Q2 '26 EPS of $4.25 on revenue of $707M (+17.2% YoY). Medpace beat estimates, reporting $4.25 vs. the $4.08 estimate.

Medpace reported Q2 '26 revenue of $707M, up 17.2% from the same quarter a year earlier.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the MEDP AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.